The glycolytic enzyme NSE is typically released from damaged neurons and has been suggested to be used as a biomarker for rapid diagnosis of various brain injuries (e.g., stroke and concussions) and for prognosis after brain surgery49. The gene discussed is ENO2; the disease is brain injury.